Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 2,954,392 5.700% | -940,000 (-24.14%) | Filing History |
| 2022-02-14 3:16 pm Sale | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 870,000 3.000% | -630,000 (-42.00%) | Filing History |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Logos Global Management LP | 145,000 3.000% | -105,000 (-42.00%) | Filing History |
| 2022-02-14 2:47 pm Sale | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Logos Global Management LP | 0 0.000% | -1,495,000 (Position Closed) | Filing History |
| 2022-02-14 2:05 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Logos Global Management LP | 150,000 0.400% | 150,000 (New Position) | Filing History |
| 2022-02-14 1:36 pm Sale | 2021-12-31 | 13G | Nkarta, Inc. NKTX | Logos Global Management LP | 0 0.000% | -1,927,180 (Position Closed) | Filing History |
| 2022-01-26 4:27 pm Sale | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 0 0.000% | -1,339,793 (Position Closed) | Filing History |
| 2021-12-27 5:25 pm Purchase | 2021-12-17 | 13G | Harpoon Therapeutics, Inc. HARP | Logos Global Management LP | 183,000 5.600% | 183,000 (New Position) | Filing History |
| 2021-12-02 4:53 pm Purchase | 2021-11-22 | 13G | COMPASS Pathways plc CMPS | Logos Global Management LP | 1,400,000 3.400% | 1,400,000 (New Position) | Filing History |
| 2021-11-15 2:24 pm Purchase | 2021-11-01 | 13G | Atreca, Inc. BCEL | Logos Global Management LP | 996,584 3.300% | 996,584 (New Position) | Filing History |
| 2021-09-29 09:30 am Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | Logos Global Management LP | 1,495,000 8.800% | 1,495,000 (New Position) | Filing History |
| 2021-09-13 5:12 pm Unchanged | 2021-09-02 | 13G | Forte Biosciences, Inc. FBRX | Logos Global Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-09-09 12:30 pm Purchase | 2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 1,339,793 9.400% | 1,339,793 (New Position) | Filing History |
| 2021-08-16 2:37 pm Purchase | 2021-08-05 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 3,894,392 7.600% | 3,894,392 (New Position) | Filing History |
| 2021-08-13 12:27 pm Purchase | 2021-08-03 | 13G | Aligos Therapeutics, Inc. ALGS | Logos Global Management LP | 114,911 6.700% | 114,911 (New Position) | Filing History |
| 2021-07-28 7:32 pm Purchase | 2021-07-19 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 1,500,000 6.200% | 1,500,000 (New Position) | Filing History |
| 2021-07-28 6:52 pm Purchase | 2021-07-19 | 13G | Kezar Life Sciences, Inc. KZR | Logos Global Management LP | 250,000 5.200% | 250,000 (New Position) | Filing History |
| 2021-06-15 12:19 pm Purchase | 2021-06-14 | 13D | ALX Oncology Holdings Inc. ALXO | Logos Global Management LP | 3,156,981 7.900% | 76,080 (+2.47%) | Filing History |
| 2020-12-03 4:06 pm Purchase | 2020-11-23 | 13D | Olema Pharmaceuticals, Inc. OLMA | Logos Global Management LP | 3,758,818 9.400% | 3,758,818 (New Position) | Filing History |
| 2020-11-19 4:05 pm Purchase | 2020-11-09 | 13G | Cogent Biosciences, Inc. COGT | Logos Global Management LP | 1,907,971 9.990% | 1,907,971 (New Position) | Filing History |